Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Research Article

JCR. 2020; 7(6): 2721-2729


COMPLICATIONS IN TREATMENT OF CORONAVIRUS THERAPY

GAURAV MISHRA, SANJAY KUMAR ASTHANA, ABHINAV TIWARI, MANOJ KUMAR SACHAN, AWADHESH KUMAR.

Abstract
The novel Covid sickness 2019 (COVID-19) flare-up began toward the beginning of December 2019 in the
capital city of Wuhan, Hubei territory, People's Republic of China, and caused a worldwide pandemic. The quantity of patients confirmed to have this infection has surpassed 9 million in excess of 215 nations, and in excess of 480 600 have kicked the bucket starting at 25 June 2020. Covids were identified during the 1960s and have as of late been identified as the reason for a Middle East respiratory disorder (MERS-CoV) flare-up in 2012 and an extreme intense respiratory condition (SARS) episode in 2003. The current SARS Covid 2 (SARS-CoV-2) is the most as of late identified. Patients with COVID-19 might be asymptomatic. Common side effects incorporate fever, dry hack and windedness. Gastrointestinal indications, for example, sickness, heaving, stomach torment and loose bowels have been accounted for; neurologically related manifestations, especially anosmia, hyposmia and dysgeusia, have likewise been accounted for. Actual assessment may find fever in over 44% of patients (and could be recorded in over 88% of patients after confirmation), expanded respiratory rate, intense respiratory illness and perhaps diminished cognizance, disturbance and disarray. This article targets introducing a state-of-the-art survey on the pathogenesis, conclusion and inconveniences of COVID-19 contamination. Presently no therapeutics have been discovered to be powerful. Investigational therapeutics are briefly talked about.

Key words: Complications, COVID-19, diagnosis, overview, pathophysiology



Similar Articles

Passive social media use and psychological well-being during the COVID-19 pandemic: The role of social comparison and emotion regulation.
Yue Z, Zhang R, Xiao J
Computers in human behavior. 2022; 127(): 107050

Using the Health Belief Model to examine travelers' willingness to vaccinate and support for vaccination requirements prior to travel.
Suess C, Maddock J, Dogru T, Mody M, Lee S
Tourism management. 2022; 88(): 104405

Does the Covid-19 pandemic affect faith-based investments? Evidence from global sectoral indices.
Dharani M, Hassan MK, Rabbani MR, Huq T
Research in international business and finance. 2022; 59(): 101537

Environmental stocks, CEO health risk and COVID-19.
Fernández-Méndez C, Pathan S
Research in international business and finance. 2022; 59(): 101509

Insufficient ventilation led to a probable long-range airborne transmission of SARS-CoV-2 on two buses.
Ou C, Hu S, Luo K, Yang H, Hang J, Cheng P, Hai Z, Xiao S, Qian H, Xiao S, Jing X, Xie Z, Ling H, Liu L, Gao L, Deng Q, Cowling BJ, Li Y
Building and environment. 2022; 207(): 108414


Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.



ScopeMed Web Sites